...
机译:脂质体阿米卡星吸入性治疗非结核性分枝杆菌肺疾病的随机试验
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland;
The University of Texas Health Science Center at Tyler, Tyler, Texas;
Insmed Incorporated, Bridgewater, New Jersey;
Insmed Incorporated, Bridgewater, New Jersey;
Insmed Incorporated, Bridgewater, New Jersey;
Insmed Incorporated, Bridgewater, New Jersey;
National Jewish Health, Denver, Colorado;
Oregon Health & Science University, Portland, Oregon;
Stanford University School of Medicine, Stanford, California;
New York University School of Medicine, New York, New York;
Medical University of South Carolina, Charleston, South Carolina;
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania;
Leonard M. Miller School of Medicine, University of Miami, Miami, Florida;
The University of Texas Health Science Center at Tyler, Tyler, Texas;
Insmed Incorporated, Bridgewater, New Jersey,Global Biopharma, Moorestown, New Jersey;
The University of Texas Health Science Center at Tyler, Tyler, Texas;
culture conversion; efficacy; safety; nontuberculous mycobacteria;
机译:脂蛋白阿米卡星用于治疗非结核性非结核性细菌性肺病(NTM-LD)的吸入性(LAI)随机,双盲,局部对照研究
机译:在答复 - Amikacin脂质体吸入悬浮液作为难治性厌备的难治性厌备的治疗选择,由厌备分枝杆菌繁殖
机译:Amikacin脂质体吸入悬浮液作为难治性无抗性的分枝杆菌肺病的治疗选择,由分枝杆菌复合物引起
机译:溃疡和非柔性皮肤细菌肉芽糖肉芽肿在猫和狗中
机译:鱼油(二十碳五烯酸和二十二碳六烯酸)对急性肺损伤患者的肺和全身炎症的II期,随机,双盲,安慰剂对照试验。
机译:脂质体阿米卡星吸入性治疗非结核性分枝杆菌肺疾病的随机试验
机译:Amikacin脂质体吸入悬浮患者治疗 - 难治性无泛细菌性肺病患者的人口药代动力学评价